Scientists engineer mice to fight Lyme disease in groundbreaking field trial

Lyme disease affects 15% of Nantucket residents and can cause facial paralysis, joint damage, and cardiac complications if untreated, as documented in patient cases.
We engineered the environment to maximize ticks. Now it bit us.
Esvelt explains how Nantucket's own history created the conditions for Lyme disease to flourish.

On the island of Nantucket, where Lyme disease has become as familiar as the sea air, scientists are asking a question as old as human ingenuity itself: when nature's cycles cause suffering, do we have both the right and the wisdom to rewrite them? Researchers at MIT have used CRISPR gene editing to create mice with heritable immunity to Lyme disease, a breakthrough that could, in theory, collapse the transmission chain keeping the illness alive on the island. The science is ready, but the deeper work — earning the trust of a community, weighing ecological consequence, and deciding who speaks for a wild species — has only just begun.

  • One in seven Nantucket residents carries Lyme disease, and for some, like a woman whose face stopped moving at 33, the damage is permanent and ongoing.
  • MIT scientists have successfully engineered lab mice whose Lyme immunity passes to their offspring, offering a way to break the tick-mouse transmission cycle without vaccines or pesticides.
  • Community meetings have drawn cautious, divided responses — residents weigh real suffering against the fear that editing wild mouse DNA could send unpredictable ripples through the food chain.
  • Regulators are considering a small field trial on a private island first, a controlled step designed to observe ecological impact before any release on Nantucket itself.
  • The project's lead scientist has pledged to walk away entirely if the community ultimately says no — framing consent, not just capability, as the true threshold for this technology.

On Nantucket, a small island off Massachusetts where one in seven residents has had Lyme disease, the illness has become part of daily life — visible in the emergency room, in chronic pain, in a young woman's face that no longer moves the way it once did. For MIT associate professor Kevin Esvelt, that burden became the motivation for an unconventional intervention: using CRISPR gene editing to engineer wild mice that are permanently immune to Lyme bacteria, passing that immunity to every generation that follows.

The logic is straightforward. White-footed mice are the primary reservoir for Lyme bacteria. When a tick bites an infected mouse, it picks up the bacteria and carries it forward. Engineer the mouse to be immune, and the tick bites but finds nothing to carry — the transmission chain breaks. Esvelt's team has already produced the first heritably immune lab mice, a milestone a decade in the making.

Nantucket's high disease burden made it an obvious target, but Esvelt also chose it for its culture of participatory democracy. He has presented his findings to residents ten times, and the response has been genuinely divided. Some see a solution to a real crisis. Others worry about what changing the mouse might mean for the hawk, the fox, the ecosystem's quieter dependencies. The island's Lyme problem, Esvelt notes, was itself a human creation — deer imported in 1926, conservation land that became ideal tick habitat, a cycle of unintended consequences that now infects its architects.

Before any release on Nantucket, scientists hope regulators will approve a small field trial on a private island, where ecological effects can be observed in relative isolation. Esvelt is clear that community consent is not a formality — if residents say no, the project stops. The science, he believes, is the easier part. What remains is the harder, older question of whether a community will choose to reshape the natural world to protect itself, and whether it can do so wisely.

On Nantucket, a 14-mile-long island off the coast of Massachusetts, one in seven residents carries the mark of Lyme disease. The tick-borne infection has become so woven into island life that the emergency room doctor keeps a giant tick mounted in his waiting room, and conversations about the disease are as routine as talk of weather. Now, a team of scientists believes they have found an unconventional way to interrupt the cycle that keeps the disease alive: by genetically engineering the wild mice that serve as the primary reservoir for Lyme bacteria.

The idea emerged from MIT associate professor Kevin Esvelt, who runs a lab called Sculpting Evolution. For the past decade, he and his team have been working to add a gene for an antibody that prevents Lyme infection directly into mouse embryos, using CRISPR—a revolutionary gene-editing tool that acts like molecular scissors, cutting DNA at precise locations and inserting new genetic material in its place. The technique is heritable, meaning the immunity passes to offspring without any need for vaccination. When a genetically engineered mouse is born, it will be immune to Lyme disease. So will its children, and their children after them.

The mechanism is elegant in its simplicity. White-footed mice are the main hosts of Lyme bacteria. When an uninfected tick bites an infected mouse, the bacteria transfer to the tick. When that tick then bites another mouse, the cycle continues. But if the mouse is immune, the tick cannot become infected. Break that link, and the transmission chain collapses. Scientists could theoretically release thousands of engineered mice on Nantucket over time, beginning in winter when the native mouse population is naturally low, allowing the genetic trait to spread through the wild population.

Esvelt chose Nantucket not only for its high burden of disease but also for its tight-knit, educated community with a strong tradition of town hall democracy. In October 2024, he and his team presented their findings to residents for the tenth time, showing that they had successfully produced the first heritably Lyme-immune laboratory mice. The response was mixed. Some residents embraced the idea as a solution to a genuine crisis. Others worried about unintended ecological consequences—tinkering with the food chain, they reasoned, could have ripple effects no one could predict. One resident who had suffered Lyme disease twice called it "a cool idea" but expressed caution about disrupting the foundation of the local ecosystem.

The human cost of inaction is visible in the island's medical offices. Dr. Timothy Lepore, who has served as Nantucket's emergency room head, sole surgeon, and medical examiner over four decades, now runs the only private practice on the island and treats dozens of Lyme patients each year. Shauna Asplint, a 33-year-old resident, was first diagnosed with Lyme at age ten. Years later, the left side of her face stopped moving—a residual effect of the disease that remains noticeable today. She experiences chronic pain throughout her body, stiffness in her neck, soreness in her ankles and hips. If left untreated, Lyme disease can spread to the heart, joints, and nervous system, causing permanent damage.

The island's Lyme problem has deep historical roots. In 1926, locals voted to import two female deer to keep a lone buck company. As the deer population grew, so did the ticks that feed on them. A single female tick can lay as many as 2,000 eggs. By the 1950s, half the island's land was placed into conservation, creating ideal habitat—untamed brush and wild grasslands—for the mice and ticks that thrive there. Esvelt frames it plainly: "We have a problem with tick-borne disease because we engineered the environment to maximize the number of ticks and maximize the number of mice that are the best hosts of Lyme disease. And it came back and bit us, literally."

Dr. Lepore, an avid falconer, supports the proposal but wants more testing to ensure ecological safety. The question he poses is fundamental: could a change in the field mouse lead to a change in the hawk? The scientists believe not, but they acknowledge the uncertainty. If federal and state regulators approve, the team plans to first release engineered mice in a small field trial on a private island, allowing them to observe ecological impacts before any potential experiment on Nantucket itself. Esvelt is clear about what success looks like: a field trial that dramatically reduces the fraction of infected ticks, causes no obvious ecological harm, and gives the community a genuine voice in deciding whether to proceed. "And then we walk away," he says, if the community says no. The technology exists. The science works. What remains is the harder question: whether a community will choose to reshape the evolution of a wild species to protect its own health.

The dream is that we can use new technologies to ensure that wild creatures can live in peace, playing their normal ecological role, but without causing disease that make people suffer.
— Kevin Esvelt, MIT associate professor
This is how we should go about developing these kinds of technologies—not just scientists in laboratories with a clever idea and then it's there.
— Kevin Esvelt, on the importance of community input
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why target the mice instead of just killing them all, or controlling the deer population?

Model

Because the mice are woven into the food chain. Kill them, and you starve the hawks, owls, snakes—everything that depends on them. The engineers realized they could leave the mice alive and thriving, just change what happens when a tick bites them.

Inventor

So you're not eliminating the mouse. You're making it invisible to the disease.

Model

Exactly. The tick still bites. The mouse still lives its life. But the bacteria can't take hold. The cycle breaks.

Inventor

How is this different from a vaccine?

Model

A vaccine requires you to choose it, to get the shot. This is heritable—it's written into the DNA. Every offspring of an engineered mouse is born immune. It's evolution on purpose, in one generation instead of thousands of years.

Inventor

That sounds like playing God.

Model

Esvelt doesn't shy from that. He says we've already engineered the environment—we brought the deer, we protected the land, we created the conditions for this plague. Now we're using the same tools to undo it. But he's also careful. He's asking the community first, not just doing it.

Inventor

What if something goes wrong? What if the mice change in some unexpected way?

Model

That's the real question. They're planning small field trials on private islands first, to watch for ecological surprises. But you can't predict everything. That's why the community has to decide if the risk of doing nothing is worse than the risk of trying.

Quer a matéria completa? Leia o original em CBS News ↗
Fale Conosco FAQ